Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
aborted, aid, art, Bluher, booked, brother, Central, Certificate, Championship, choice, Citrulline, customary, declared, defense, driven, drop, encumbered, explained, Fighting, foot, Franklin, Gary, governmental, GRQ, handling, heavy, indemnification, indirectly, joint, loaded, main, Malate, Melechdavid, multiplied, overview, patent, point, post, preferential, President, private, pronouncement, protein, proximity, Refer, repay, Secretary, square, subscription, Tawnsaura, title, tranche, transition, transported, truck, typically, UFC, underwriting, Vice, York
Removed:
ability, acceptable, aged, anticipated, bifurcated, boost, bringing, classification, commence, consultant, dependent, doubt, execute, exempt, expire, explore, finance, free, fund, funding, incur, insufficient, intent, investor, involving, issuer, leveraging, meet, percent, pertain, preparing, promulgated, Proposition, publicly, ranging, realization, Reclassification, recovery, reduced, Regulation, relating, reliance, research, response, shown, strategic, substantial, sustain, thereunder, traded, traditional, unable, view
Filing tables
Filing exhibits
Related press release
MSLPQ similar filings
Filing view
External links
Exhibit 32.1
Section 1350 CERTIFICATION
In connection with this Quarterly Report of MusclePharm Corporation (the “Company”), on Form 10-Q for the quarter ended March 31, 2013, as filed with the U.S. Securities and Exchange Commission on the date hereof (the “Report”), I, Brad J. Pyatt, Principal Executive Officer of the Company, certify pursuant to 18 U.S.C. Section. 1350, as adopted pursuant to Section. 906 of the Sarbanes-Oxley Act of 2002, that:
(1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and |
(2) | The information contained in the Report, fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: May 15, 2013 | By: | /s/ Brad J. Pyatt |
Brad J, Pyatt | ||
Principal Executive Officer |